Authors: Perret, J Bourrin, JC Chedru, F Carpentier, F Davous, P Hinault, P Warter, JM Boisson, D Solignac, M David, JP Dien, J Dupuy, D Emile, J Fischer, G Galletti, P Honorat, A Kopp, M Le Guyader, J Maupetit, J Oriol, JM Deseilligny, CP Prince, P Benabid, A Bleton, JP Blond, S Bonnet, AM Broussolle, P Cesaro, P Chaperon, J Damier, P Defer, G Destee, A Fenelon, G N'guyen, JP Pelissier, J Pollak, P Rascol, O Tison, F Tranchant, C Viallet, F Vidailhet, M Ziegler, M Marion, MH Brefel-Courbon, C Derkinderen, P Gayraud, D Krystowiak, P Simon, O Thobois, S Vercueil, L

Citation: J. Perret et al., Parkinson's disease: Diagnostic and therapeutic criteria, PRESSE MED, 30(8), 2001, pp. 379-385

Authors: Blin, O Simon, N Jouve, E Habib, M Gayraud, D Durand, A Bruguerolle, B Pisano, P

Citation: O. Blin et al., Pharmacokinetic and pharmacodynamic analysis of sedative and amnesic effects of lorazepam in healthy volunteers, CLIN NEUROP, 24(2), 2001, pp. 71-81

Authors: Viallet, F Witjas, T Gayraud, D Pelletier, J Regis, J

Citation: F. Viallet et al., Tremor and movement disorders in multiple sclerosis: indications for symptomatic treatment, REV NEUROL, 157(8-9), 2001, pp. 1079-1084

Authors: Gayraud, D

Citation: D. Gayraud, Re-education and Parkinson's disease, REV NEUROL, 156, 2000, pp. 175-189

Authors: Blin, O Jacquet, A Callamand, S Jouve, E Habib, M Gayraud, D Durand, A Bruguerolle, B Pisano, P

Citation: O. Blin et al., Pharmacokinetic-pharmacodynamic analysis of mnesic effects of lorazepam inhealthy volunteers, BR J CL PH, 48(4), 1999, pp. 510-512